20525 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS
#302Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#303W/O/W microemulsions for ocular administration
#304Immunogenic trehalose compounds and uses thereof
#305Maribavir isomers, compositions, methods of making and methods of using
#306Composition and methods of treating acne and photoaging
#307OIL-SOLUBLE DRUG CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF
#308ALDOXORUBICIN COMBINATION TREATMENTS AND METHODS
#309Methods for treating arenaviridae and coronaviridae virus infections
#310Inhibitors of influenza virus replication and uses thereof
#311INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES
#312WOUND HEALING DEVICE AND METHODS FOR WOUND HEALING
#313Compositions and methods for treating parasitic diseases
#314Method of treating, reducing, or alleviating a medical condition in a patient
#315Uses
#316Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#3172,7-dibromospiro[fluorene-9,4′-piperidine] compounds
#318Multivalent fucose derivatives for use as a drug
#319COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS
#320Compositions and methods for treating an infection
#321TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#322METHODS FOR DETECTING AND TREATING LOW-VIRULENCE INFECTIONS
#323TOPICAL DERMATOLOGIC ACNE TREATMENT CREAM COMPOSITION AND METHOD OF MANUFACTURE
#324COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ANALOGS THEREOF, INCLUDING MEISOINDIGO
#3254′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
#326METHODS FOR THE PREPARATION OF RIBOSIDES
#327Treatment of metabolic disorders in feline animals
#328COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS
#329EYE DROP FOR TREATING DRY EYE
#330Heterobifunctional Pan-Selectin Antagonists Having a Triazole Linker
#331Methods of treatment for bacterial infections
#332Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#333Drug formulations
#334Compounds for the prevention and treatment of diseases and the use thereof
#335CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
#336Human helicase DDX3 inhibitors as therapeutic agents
#337Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
#338Betalain compositions and methods therefor
#339COMPOUNDS AND COMPOSITIONS FOR EXTENDING LIFESPAN OF A SUBJECT
#340TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#341Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
#342ANTIVIRAL COMPOUNDS
#343Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof
#344Maribavir isomers, compositions, methods of making and methods of using
#345Compounds, devices, and uses thereof
#346Compositions and methods for treating an infection
#347Stimulating platelet generation by activating mitochondrial biogenesis
#348Aza-pyridone compounds and uses thereof
#349Lactam compound, preparation method and use thereof
#350Immunodulating small molecules
#351TETRACYCLIC COMPOUND
#352TRIAZOLE-CONTAINING MACROLIDES AND OPHTHALMIC USES THEREFOR
#353Compositions and Methods for Treating Epithelial Cancer
#354Prosthetic tissue valves
#355IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#356Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease
#357SELENOGALACTOSIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH GALECTIN AND THE USE THEREOF
#358Retinoid Topical Compositions and Methods for Treating Skin Conditions
#359Agent for promoting angiogenesis and methods and uses thereof
#360Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-1H-benzimidazole
#361Taste masking product
#362Antiviral compounds
#363Ready-To-Use Liquid Parenteral Formulations Of Ribavirin
#364Aryl hydrocarbon receptor modulators
#365Light-activated compositions and methods using the same
#366Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
#367Modulators of toll-like receptors
#368Controlled release pharmaceutical formulations of nitazoxanide
#369Alpha-D-galactoside inhibitors of galectins
#370COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#371Identification of granins as the pathogenic factor of alzheimer's disease and compositions and methods for inhibiting granin aggregation and treating alzheimer's disease
#372AZA-pyridone compounds and uses thereof
#373Heterocyclic compounds for the treatment of arenavirus
#374Advanced methods and systems for treating cell proliferation disorders
#375Medicinal vaginal lactobacillus cocktail
#376Use of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) agonists to improve ex vivo expansion of tumor infiltrating lymphocytes (TILS)
#377Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#378ARYL HYDROCARBON RECEPTOR MODULATOR
#379Antiviral compositions for the treatment of infections linked to coronaviruses
#380ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS
#381Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
#382Methods and compositions for treating hepatitis C virus
#383Antiviral compounds
#384Compounds for treatment of lipoprotein metabolism disorders
#385Methods for treating filoviridae virus infections
#386Biofilm formation to define risk for colon cancer
#387Methods for treating arenaviridae and coronaviridae virus infections
#388Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof
#389Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy
#390Antimicrobial composition combinations comprising star shaped peptide polymers
#391Cancer chemotherapy employing halogenated analogs of thymidine
#392COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS
#393Pharmaceutical compositions comprising silica microspheres
#394Vaccine comprising drug and parasite administration
#395Inhibition of Zika Virus Infection
#396COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#397Methods for treating degenerative disc disease and chronic lower back pain
#398TREATING OCULAR NEOVASCULARIZATION
#399Combination pharmaceutical agents as RSV inhibitors
#400Dispersion process of adapalene in a gel preparation
#401Compositions and methods for treating an infection
#402Antibacterial agents
#403Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
#404Desensitizing mast cells by co-presentation of antigens with high affinity mast cell siglec ligands
#405Inhibition of galectin 3 binding to the airway epithelial surface to treat or prevent septic shock resulting from influenza and subsequent pneumococcal pneumonia infection
#406Novel Compounds and Compositions and Methods of Use
#407Methods and materials for reducing the risk of infections
#408Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#409COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS
#410Mannose derivatives for treating bacterial infections
#411Use of DDX3 inhibitors as antiproliferative agents
#412Oil foamable carriers and formulations
#413Mithramycin derivatives having increased selectivity and anti-cancer activity
#414Brain-targeting prodrug for AMPA receptor synergist, and pharmaceutical applications thereof
#415ANTIVIRAL CONJUGATES OF POLYANIONIC POLYMER AND ANTIVIRAL DRUG
#416Methods and compositions for treating cancer
#417Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#418Compositions and methods for treating an infection
#419Foamable compositions, breakable foams and their uses
#420Combination products for the treatment of RSV
#421Methods and compounds for treating malaria
#422Silane-Containing Heterocyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases
#423METHODS FOR TREATING DIABETES
#424Particulate delivery systems
#425Drug formulations
#426METHODS FOR TREATING RESISTANT DISEASES USING TRIAZOLE CONTAINING MACROLIDES
#427Heterobifunctional Pan-Selectin Antagonists Having a Triazole Linker
#428Skin-like condoms having active ingredients to enhance a male erection and a female arousal
#429Bifunctional cytotoxic agents
#430Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs
#431METHODS AND COMPOSITIONS USING AMPK ACTIVATORS FOR PHARMACOLOGICAL PREVENTION OF CHRONIC PAIN
#432Compositions and methods of treating acne and photoaging
#433Conditioning regimens and methods for inducing mixed chimerism
#434Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#435Methods for treating Filoviridae virus infections
#436NEW COMBINATION THERAPIES FOR TREATING NEUROLOGICAL DAMAGE
#437Hyaluronate Compositions
#438Inhibition of multiple pathogenic agents using bithionol
#439Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
#440GLUCOPYRANOSIDE COMPOUND
#441D-amino acid compounds for liver disease
#442IMMEDIATE RELEASE CLINDAMYCIN DELIVERY COMPOSITION AND FORMULATION
#443ANTIVIRAL COMPOUNDS
#444ANTIVIRAL COMPOUNDS
#445MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#446METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUSES AND PESTIVIRUSES
#447Mannose derivatives useful for treating pathologies associated with adherent
#448Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#449INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS
#450METHODS FOR DETECTING AND TREATING LOW-VIRULENCE INFECTIONS
#451Compositions and methods relating to galectin detection
#452Hepatitis C virus inhibitors
#453CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS
#454PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES
#455Cladribine regimen for treating multiple sclerosis
#456Multi-functional Composition and Preparation Method and Application Thereof
#4574'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
#458INHIBITION OF HSV-1-ASSOCIATED CORNEAL NEOVASCULARIZATION USING INHIBITORS OF CYCLIN-DEPENDENT KINASE 9
#459COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#460System, retainer and method of preventing and treating nosocomial infections including methicillin-resistant infections
#461Thienopyridine derivative for the treatment of hepatitis C infections
#462ANTIVIRAL COMPOUNDS
#463METHODS AND COMPOSITIONS FOR TREATING THYROID-RELATED MEDICAL CONDITIONS WITH REDUCED FOLATES
#464Use of levocetirizine and montelukast in the treatment of traumatic injury
#465Methods for Treating HCV
#466Compositions and methods that modulate white blood cells or neutrophils in a companion animal
#467Antibacterial products
#468METHODS FOR THE TREATMENT OF ROSACEA
#469Once-daily treatment of pulmonary fibrosis
#470Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection
#471Anthracycline prodrugs and methods of making and using the same
#472Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof
#473DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF
#474Treating or preventing nephrogenic diabetes insipidus
#475ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES
#476Modulators of toll-like receptors
#477Controlled release pharmaceutical formulations of nitozoxanide
#478Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
#479Skin Solution with Solubilized Bakuchiol
#480NOVEL CRYSTALLINE FORMS OF AN ANTIVIRAL BENZIMIDAZOLE COMPOUND
#481Light-activated compositions and methods using the same
#482Methods for Treating HCV
#483Antiviral compositions for treating the flu
#484Advanced methods and systems for treating cell proliferation disorders
#485Methods for treating ocular inflammatory disorders
#486HUMAN HELICASE DDX3 INHIBITORS AS THERAPEUTIC AGENTS
#487Tryptophan is a pro-drug for infectious diseases and cancers
#488ANTIVIRAL COMPOUNDS
#489Methods and materials for reducing the risk of infections
#490HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS
#491Methods and compositions for treating eukaryotic infections via altering aggregation dynamics of Raptor/KOG1
#492Methods for treating a cytomegalovirus infection
#493Antiviral agents directed against respiratory syncytial virus
#494WOUND HEALING COMPOUND
#495Methods of treating hepatitis E viral infection
#496COMPOSITIONS AND METHODS FOR TREATING HEPATITIS C VIRUS
#497ANTIVIRAL COMPOUNDS
#498Anthracycline formulations
#499COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#500Compositions and methods for treating an infection
#501Compositions and methods for treating an infection
#5026-aryl-9-glycosylpurines and use thereof
#503Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#504Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
#505NEW INDICATION OF CARDIOVASCULAR DRUGS FOR PREPARATION OF CANCER INHIBITION PHARMACEUTICAL COMPOSITION
#506Indication of antibiotic drugs for preparation of cancer inhibition pharmaceutical composition
#507Compositions and methods for treating viral infections
#508Antitumor activity of multi-kinase inhibitors in colorectal cancer
#509METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS
#510Method of isolating anti-viral ingredients from , compositions comprising them and their medical use
#511Compounds and compositions and methods of use
#512Compositions and methods for treating epithelial cancer
#513METHODS FOR THE TREATMENT OF ROSACEA
#514IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#515Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy
#516REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS
#517Thiazolidinone compounds and use thereof
#518Compounds and methods for treating bacterial infections
#519TREATING VIRAL HEMORRHAGIC FEVER WITH NK-92 CELLS
#520Combination treatment of SGLT2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals
#521TRANSDERMAL ABSORPTION ENHANCER AND TRANSDERMAL ABSORPTION ENHANCEMENT AID
#522Macrocyclic inhibitors of hepatitis C virus
#523TREATMENTS OF HEPATITIS C VIRUS INFECTION
#524Cancer chemotherapy employing halogenated analogs of thymidine
#525Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#526METHODS, COMPOSITIONS, AND FORMULATIONS FOR PREVENTING OR REDUCING ADVERSE EFFECTS IN A PATIENT
#527Foamable compositions, breakable foams and their uses
#528Betalain compositions and methods therefor
#529Combination formulation of two antiviral compounds
#530Macrocyclic inhibitors of flaviviridae viruses
#531Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections
#532Methods for treating HCV
#533Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels and rhamnose-linked gaels as cytotoxic agents against epithelial cancer cells and cancer stem cells
#534Oil foamable carriers and formulations
#535Antiviral composition containing material involved in phosphatidylcholine synthesis pathway
#536Composition for preventing or treating muscle wasting-related disease and use thereof
#537COMPOSITIONS AND METHODS FOR TREATING DIABETES AND LIVER DISEASES
#538Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
#539Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#540A NOVEL PHARMACEUTICAL COMPOSITION OF SOFOSBUVIR AND RIBAVIRIN
#541Method of diagnosing and treating Epstein Barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
#542MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF SOFOSBUVIR AND RIBAVIRIN
#543Inhibitors and methods of inhibiting bacterial and viral pathogens
#544Combination therapy using ribavirin as elF4E inhibitor
#545Heterocyclic compounds and methods of use thereof
#546Inorganic-organic hybrid compound
#547PHARMACEUTICAL COMBINATIONS OF SOFOSBUVIR AND RIBAVIRIN
#548PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES
#549GALACTOSIDE INHIBITORS FOR NEW USES
#550MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#551Treatment of metabolic disorders in equine animals
#552Methods for treating arenaviridae and coronaviridae virus infections
#553Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methods
#554Methods and Compositions for Inhibiting Clostridium difficile Spore Germination and Outgrowth
#555Use of levocetirizine and montelukast in the treatment of traumatic injury
#556TRANSLOCATION OF NON-NATURAL CHEMICAL ENTITIES THROUGH ANTHRAX PROTECTIVE ANTIGEN PORE
#557COMBINATION THERAPY FOR TREATING HCV INFECTION
#558Composition and methods of treating acne and photoaging
#559Purine derivatives as CD73 inhibitors for the treatment of cancer
#560Effective treatment of ovarian cancer using triciribine and related compounds
#561Treating ocular neovascularization
#562Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#563Methods of treating coronavirus infection
#564Maribavir isomers, compositions, methods of making and methods of using
#565METHODS OF TREATING GLAUCOMA USING AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS
#566Pharmaceutical compositions comprising silica microspheres
#567METHODS FOR ANALYSIS OF SOMATIC MOBILE ELEMENTS, AND USES THEREOF
#568Treating or preventing nephrogenic diabetes insipidus
#569FORMULATIONS OF ACADESINE
#570DELIVERY OF PHARMACEUTICAL ACTIVE INGREDIENTS THROUGH THE SKIN AND HAIR FOLLICLES INTO DERMIS AND TRANSDERMAL DELIVERY
#571COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS
#572Drug formulations
#573Composition and method of use for combinations of anti-viral protease, polymerase inhibitors and natural bioactive compounds in the treatment of hepatitis C infection
#574Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease
#575METHODS FOR TREATING HCV
#576Process for preparing antiviral compounds
#577E-SELECTIN INHIBITION WORKS IN COMBINATION WITH LOW-MOLECULAR WEIGHT HEPARIN TO DECREASE VENOUS THROMBOSIS AND BLEEDING RISK
#578Use of compounds that are able to increase the serum IGF-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced IGF-1 serum level in humans and animals
#579MEANS AND METHODS FOR INCREASING ANTIBIOTIC ACTIVITY
#580Solid forms of a thiophosphoramidate nucleotide prodrug
#581Methods for Treating HCV
#582Antibacterial phage, phage peptides and methods of use thereof
#583ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE
#584Estrogen receptor modulators and uses thereof
#585Bis-amide derivative and use thereof
#586COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL DISEASES WITH PDE4 MODULATORS
#587Glycoclusters and their pharmaceutical use as antibacterials
#588Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a Hepatitis C virus infection
#589Fibrosis Inhibiting Compounds and Methods of Use Thereof in the Prevention or Treatment of Fibrosing Diseases
#590THIOPHENE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OFUSE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
#591Use of Let-7g to down regulate NS5B gene, core protein and viral load of hepatitis C virus
#592METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS
#593Controlled release pharmaceutical formulations of nitazoxanide
#594Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
#595METHODS FOR TREATING HCV
#596Treatment of Hepatitis C Virus Infection with Alisporivir
#597Mannose derivatives for treating bacterial infections
#598Macrocyclic inhibitors of hepatitis C virus
#599Aza-pyridone compounds and uses thereof
#600Biofilm formation to define risk for colon cancer